Delivery Order SPE2DB22D9367-SPE2DB24FSZ38

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract worth $8,339.18 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 120 tablets of the pharmaceutical drug Xtandi (40 mg), with a completion date of February 26, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is for the delivery of 120 capsules of the drug Xtandi (40 mg) to support the medical supply needs of military health facilities. The contract has an ultimate completion date of December 12, 2024. DMS Pharmaceutical Group Inc. holds a larger single-award...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,169.59 contract is for the delivery of Xtandi 80 mg tablets. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical items, including branded and generic prescription drugs,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,565,440,973 units of the pharmaceutical Xtandi 40 mg capsule. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $41,695.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xtandi 40 mg tablets (120 count). This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to order a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order contract, which is not associated with any set-aside designations, is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. Under this IDC, the DLA can issue delivery orders for a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a $4,169.59 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the supply of 4,566,561,052 units of the prescription drug Xtandi 40 mg tablet, with a completion date of November 27, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
The Defense Logistics Agency (DLA) awarded a $4,169.59 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 60 tablets of the prescription drug Xtandi 80 mg. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which provides a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a $4,169.59 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, which is part of the larger SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999, covers the delivery of Xtandi 80 mg tablets to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 120 units of the prescription drug Xtandi 40 mg capsules. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC enables the DLA to issue delivery...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSZ38
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $8,339.18 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the drug Xtandi 80 mg tablets and has an ultimate completion date of August 27, 2024.

This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 11/25/24, 9:03 AM